On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
Chu PS, Nakamoto N, Taniki N, Ojiro K, Amiya T, Makita Y, Murata H, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ugamura A, Ikura A, Takeda K, Ebinuma H, Saito H, Kanai T.
Chu PS, et al. Among authors: ebinuma h.
PLoS One. 2017 Jun 15;12(6):e0179096. doi: 10.1371/journal.pone.0179096. eCollection 2017.
PLoS One. 2017.
PMID: 28617830
Free PMC article.